These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3391372)

  • 41. Comparable efficacy of low- versus high-dose induction corticosteroid treatment in autoimmune pancreatitis.
    Buijs J; van Heerde MJ; Rauws EA; de Buy Wenniger LJ; Hansen BE; Biermann K; Verheij J; Vleggaar FP; Brink MA; Beuers UH; Kuipers EJ; Bruno MJ; van Buuren HR
    Pancreas; 2014 Mar; 43(2):261-7. PubMed ID: 24518506
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Natural history, clinical features, and treatment of autoimmune hepatitis.
    Czaja AJ
    Semin Liver Dis; 1984 Feb; 4(1):1-12. PubMed ID: 6710168
    [No Abstract]   [Full Text] [Related]  

  • 43. Corticosteroid-responsive cryptogenic chronic hepatitis: evidence for seronegative autoimmune hepatitis.
    Gassert DJ; Garcia H; Tanaka K; Reinus JF
    Dig Dis Sci; 2007 Sep; 52(9):2433-7. PubMed ID: 17429719
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Survival in chronic hepatitis B. An analysis of 379 patients.
    Weissberg JI; Andres LL; Smith CI; Weick S; Nichols JE; Garcia G; Robinson WS; Merigan TC; Gregory PB
    Ann Intern Med; 1984 Nov; 101(5):613-6. PubMed ID: 6486592
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Importance of adequate immunosuppressive therapy for the recovery of patients with "life-threatening" severe exacerbation of chronic hepatitis B.
    Fujiwara K; Yokosuka O; Kojima H; Kanda T; Saisho H; Hirasawa H; Suzuki H
    World J Gastroenterol; 2005 Feb; 11(8):1109-14. PubMed ID: 15754390
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Prognostic value of procalcitonin, endotoxin and common inflammatory markers combining MELD score in patients with chronic severe hepatitis].
    Zhou Q; Tan D; Yi Z; Zheng Y; Lu M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 38(4):388-94. PubMed ID: 23645239
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Chronic active hepatitis: the clinical, biochemical and histopathological correlations].
    Subauste MC
    Rev Gastroenterol Peru; 1989; 9(1):29-40. PubMed ID: 2490974
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ursodeoxycholic acid therapy in chronic active hepatitis.
    Bateson MC
    Postgrad Med J; 1990 Sep; 66(779):781-3. PubMed ID: 2235818
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Treatment of autoimmune chronic active hepatitis and of primary biliary cirrhosis].
    Renner EL
    Schweiz Med Wochenschr; 1994 Mar; 124(12):495-501. PubMed ID: 8159985
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Steroid therapy in fulminant hepatic failure secondary to autoimmune hepatitis.
    Viruet EJ; Torres EA
    P R Health Sci J; 1998 Sep; 17(3):297-300. PubMed ID: 9883478
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Autoimmune hepatitis in children.
    Raghuveera AL; Rohrbach MA; Elitsur Y
    W V Med J; 1996; 92(6):316-9. PubMed ID: 8993195
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prednisone for chronic active hepatitis: pharmacokinetics and serum binding in patients with chronic active hepatitis and steroid major side effects.
    Uribe M; Go VL; Kluge D
    J Clin Gastroenterol; 1984 Aug; 6(4):331-5. PubMed ID: 6481116
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic factors for chronic severe hepatitis and construction of a prognostic model.
    Li Q; Yuan GY; Tang KC; Liu GW; Wang R; Cao WK
    Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):40-4. PubMed ID: 18234637
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development and early prognosis of esophageal varices in severe chronic active liver disease (CALD) treated with prednisone.
    Czaja AJ; Wolf AM; Summerskill WH
    Gastroenterology; 1979 Oct; 77(4 Pt 1):629-33. PubMed ID: 313890
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Course of chronic virus hepatitis B in children and attempts at modifying its treatment].
    Kowalik-MikoĊ‚ajewska B
    Pol Tyg Lek; 1993 Mar 15-29; 48(11-13):258-60. PubMed ID: 7694262
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Severe chronic active hepatitis (autoimmune type) mimicked by coinfection of hepatitis C and human immunodeficiency viruses.
    Berk L; Schalm SW; Heijtink RA
    Gut; 1991 Oct; 32(10):1198-200. PubMed ID: 1955176
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chronic active hepatitis and related disorders.
    Larcher V
    Clin Gastroenterol; 1986 Jan; 15(1):173-98. PubMed ID: 3082542
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Patients with chronic hepatitis--potential risks when undergoing dental surgery: review and case report.
    Reddi S; Garg AK
    Spec Care Dentist; 1994; 14(6):241-5. PubMed ID: 7754461
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel histological lesion in glucocorticoid-responsive chronic hepatitis.
    Pratt DS; Fawaz KA; Rabson A; Dellelis R; Kaplan MM
    Gastroenterology; 1997 Aug; 113(2):664-8. PubMed ID: 9247489
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Frequency and significance of serum alpha-fetoprotein elevation in severe hepatitis B surface antigen-negative chronic active hepatitis.
    Czaja AJ; Beaver SJ; Wood JR; Klee GG; Go VL
    Gastroenterology; 1987 Oct; 93(4):687-92. PubMed ID: 2442060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.